This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.2337/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73742012
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article scientifique publié en 1997 scientific article published on 01 October 1997 наукова стаття, опублікована в жовтні 1997 im Oktober 1997 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'ochobre de 1997
p:P577
wds:Q73742012-7EE5B0F5-68D9-4715-9EE2-6E01C283C84B
wdt:P577
1997-10-01T00:00:00Z
p:P407
wds:Q73742012-6CDD6530-B043-482F-9BED-B9C29FF11DA3
wdt:P407
wd:Q1860
p:P2093
wds:Q73742012-31F4371E-945E-43B2-99AB-47C6574630E8 wds:Q73742012-9D3CABC2-2112-40C9-9CD3-9786C7D6F015 wds:Q73742012-F979A21B-5143-4EB6-8231-0F1E77BD93A3
wdt:P2093
P Oskarsson J G Ljunggren P E Lins
rdfs:label
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
skos:prefLabel
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
schema:name
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
p:P1476
wds:Q73742012-1FD1F364-911D-4F6D-9BBF-CF3BE8F4A486
wdt:P1476
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
p:P304
wds:Q73742012-D1077BE8-1E81-4B34-B4E4-0BF92BE7E74F
wdt:P304
1594-1597
p:P31
wds:Q73742012-C00BFC26-ACCD-431E-9438-3F8F0C258D8C
wdt:P31
wd:Q13442814
p:P698
wds:Q73742012-98CCC059-6F66-4A5C-BA01-75C6886B44FE
wdtn:P698
n11:9314641
wdt:P698
9314641
p:P1433
wds:Q73742012-54E61BDE-12C7-4F30-812D-862BE4F84FDD
wdt:P1433
wd:Q5270111
p:P433
wds:Q73742012-BD80C86D-B953-4729-AFA1-E835F61F398A
p:P478
wds:Q73742012-A9CE4EEB-7CE4-46E0-9888-1C0519606AFE
wdt:P433
10
wdt:P478
20
p:P356
wds:Q73742012-6C4D28E9-2C0E-4ED9-A747-D9F7FECC8E83
wdtn:P356
n10:DIACARE.20.10.1594
wdt:P356
10.2337/DIACARE.20.10.1594